{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:06:49Z","timestamp":1792616809661,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaip.2025.02.012","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:35:31Z","timestamp":1740137731000},"page":"1649-1661.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Greenhouse Gas Emissions Associated With Severe Asthma Care in the United Kingdom"],"prefix":"10.1016","volume":"13","author":[{"given":"Alex","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Khezrian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam G.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soram","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Quint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitasha","family":"Rupani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Rapsomaniki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Menzies-Gow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8003-7601","authenticated-orcid":false,"given":"Trung N.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.02.012_bib3","doi-asserted-by":"crossref","first-page":"964987","DOI":"10.3389\/falgy.2022.964987","article-title":"Climate change and allergic diseases: an overview","volume":"3","author":"Singh","year":"2022","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaip.2025.02.012_bib5","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0140-6736(23)02746-0","article-title":"Health day at COP28: a hard-won (partial) gain","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.02.012_bib7","doi-asserted-by":"crossref","first-page":"e072328","DOI":"10.1136\/bmj-2022-072328","article-title":"Towards net zero: asthma care","volume":"381","author":"Smith","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2025.02.012_bib8","author":"Asthma Day"},{"key":"10.1016\/j.jaip.2025.02.012_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/thoraxjnl-2019-213744","article-title":"Carbon footprint impact of the choice of inhalers for asthma and COPD","volume":"75","author":"Janson","year":"2020","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.02.012_bib10","author":"Asthma+Lung"},{"key":"10.1016\/j.jaip.2025.02.012_bib11","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/thoraxjnl-2020-215168","article-title":"Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era","volume":"76","author":"Jackson","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.02.012_bib12","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","article-title":"Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR)","volume":"157","author":"Wang","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.02.012_bib13","doi-asserted-by":"crossref","DOI":"10.3399\/BJGPO.2023.0015","article-title":"Healthcare costs associated with short-acting \u03b2(2)-agonists in asthma: observational UK SABINA study","volume":"7","author":"Attar-Zadeh","year":"2023","journal-title":"BJGP Open"},{"key":"10.1016\/j.jaip.2025.02.012_bib15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/13696998.2022.2063603","article-title":"Carbon footprint and associated costs of asthma exacerbation care among UK adults","volume":"25","author":"Kponee-Shovein","year":"2022","journal-title":"J Med Econ"},{"key":"10.1016\/j.jaip.2025.02.012_bib17","first-page":"7","article-title":"Severe asthma\u2014a pragmatic guide for primary care practitioners","volume":"25","author":"Holmes","year":"2022","journal-title":"Primary Care Respir Update"},{"key":"10.1016\/j.jaip.2025.02.012_bib20","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.jaip.2020.11.053","article-title":"Potential severe asthma hidden in UK primary care","volume":"9","author":"Ryan","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.02.012_bib21","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00660-2022","article-title":"Benefits of specialist severe asthma management: demographic and geographic disparities","volume":"60","author":"Redmond","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.02.012_bib22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1183\/13993003.00220-2016","article-title":"A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use","volume":"48","author":"van der Meer","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.02.012_bib23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaip.2016.12.030","article-title":"A structured approach to specialist-referred difficult asthma patients improves control of comorbidities and enhances asthma outcomes","volume":"5","author":"Tay","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.02.012_bib24","first-page":"A159","article-title":"What is the severe asthma patient journey to biologic initiation in UK severe asthma centres?","volume":"77","author":"Rupani","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.02.012_bib25","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1093\/ije\/dyz034","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD) Aurum","volume":"48","author":"Wolf","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaip.2025.02.012_bib26","unstructured":"Clinical Practice Research Datalink. Accessed November 27, 2024. https:\/\/doi.org\/10.48329\/t89s-kf12."},{"key":"10.1016\/j.jaip.2025.02.012_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclepro.2019.119860","article-title":"Environmental impacts of healthcare and pharmaceutical products: influence of product design and consumer behaviour","volume":"253","author":"Jeswani","year":"2020","journal-title":"J Clean Prod"},{"key":"10.1016\/j.jaip.2025.02.012_bib29","article-title":"Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment","volume":"7","author":"Panigone","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jaip.2025.02.012_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028763","article-title":"Costs of switching to low global warming potential inhalers. An economic and carbon footprint analysis of NHS prescription data in England","volume":"9","author":"Wilkinson","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2025.02.012_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/thorax-2023-220259","article-title":"Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study","volume":"79","author":"Wilkinson","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.02.012_bib35","article-title":"Statistical bulletin. Demography and households","year":"2021","journal-title":"Census"},{"key":"10.1016\/j.jaip.2025.02.012_bib36","article-title":"UK-wide inhaler recycling scheme launched in push to reduce NHS emissions","year":"2023","journal-title":"Hospital Times"},{"key":"10.1016\/j.jaip.2025.02.012_bib37","doi-asserted-by":"crossref","first-page":"4190","DOI":"10.1007\/s12325-020-01444-5","article-title":"Asthma-related health outcomes associated with short-acting \u03b2(2)-agonist inhaler use: an observational UK study as part of the SABINA global program","volume":"37","author":"Bloom","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2025.02.012_bib38","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s12325-020-01233-0","article-title":"SABINA: an overview of short-acting \u03b2(2)-agonist use in asthma in European Countries","volume":"37","author":"Janson","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2025.02.012_bib39","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01402-2021","article-title":"Short-acting \u03b2(2)-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study","volume":"59","author":"Bateman","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.02.012_bib40","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1007\/s12325-023-02663-2","article-title":"Greenhouse gas emissions from respiratory treatments: results from the SABA CARBON International Study","volume":"40","author":"Alzaabi","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2025.02.012_bib41","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.rmed.2017.08.014","article-title":"The impact of inappropriate use of short acting beta agonists in asthma","volume":"131","author":"FitzGerald","year":"2017","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2025.02.012_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-028995","article-title":"Understanding reliever overuse in patients purchasing over-the-counter short-acting beta2 agonists: an Australian community pharmacy-based survey","volume":"9","author":"Azzi","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2025.02.012_bib43","first-page":"1","article-title":"Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice","volume":"9","author":"Price","year":"2016","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2025.02.012_bib44","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaip.2016.11.007","article-title":"Identifying risk of future asthma attacks using UK medical record data: a respiratory effectiveness group initiative","volume":"5","author":"Blakey","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.02.012_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01872-2019","article-title":"Overuse of short-acting \u03b2(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme","volume":"55","author":"Nwaru","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.02.012_bib46","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.jaip.2022.02.047","article-title":"Short-acting beta-2-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America","volume":"10","author":"Quint","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.02.012_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40733-016-0029-3","article-title":"Asthma costs and social impact","volume":"3","author":"Nunes","year":"2017","journal-title":"Asthma Res Pract"},{"key":"10.1016\/j.jaip.2025.02.012_bib48","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-017-0409-3","article-title":"The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA","volume":"17","author":"Suruki","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2025.02.012_bib49","article-title":"Reductions in inhaler greenhouse gas emissions by addressing care gaps in asthma and chronic obstructive pulmonary disease: an analysis","volume":"10","author":"Gagn\u00e9","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jaip.2025.02.012_bib50","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1378\/chest.14-3056","article-title":"Dedicated severe asthma services improve health-care use and quality of life","volume":"148","author":"Gibeon","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.02.012_bib51","doi-asserted-by":"crossref","first-page":"00685","DOI":"10.1183\/23120541.00685-2022","article-title":"Improving asthma care through implementation of the SENTINEL programme: findings from the pilot site","volume":"9","author":"Crooks","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.02.012_bib52","first-page":"4578","article-title":"Carbon footprint of maintenance and reliever therapy (MART) versus maintenance plus SABA (Mx+SABA) regimens for asthma: results from the healthCARe-Based envirONmental cost of treatment (CARBON) programme","volume":"60","author":"Bell","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.02.012_bib53","unstructured":"Clinical Practice Research Datalink. Accessed November 27, 2024. https:\/\/doi.org\/10.48329\/t89s-kf12."},{"key":"10.1016\/j.jaip.2025.02.012_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclepro.2019.117733","article-title":"Life cycle environmental impacts of inhalers","volume":"237","author":"Jeswani","year":"2019","journal-title":"J Cleaner Production"},{"key":"10.1016\/j.jaip.2025.02.012_bib55","article-title":"Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment","volume":"7","author":"Panigone","year":"2020","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jaip.2025.02.012_bib56","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s12325-020-01233-0","article-title":"SABINA: an overview of short-acting \u03b22-agonist use in asthma in European countries","volume":"37","author":"Janson","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2025.02.012_bib57","first-page":"3183","article-title":"Life cycle assessment (LCA) and cradle-to-grave (CTG) carbon footprint of a multidose reservoir dry powder inhaler","volume":"56","author":"Borenius","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.02.012_bib60","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s12325-019-01028-y","article-title":"Reduced environmental impact of the reusable Respimat\u00ae Soft MistTM inhaler compared with pressurised metered-dose inhalers","volume":"36","author":"H\u00e4nsel","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2025.02.012_bib61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13223-017-0202-0","article-title":"Asthma pressurised metered dose inhaler performance: propellant effect studies in delivery systems","volume":"13","author":"Sellers","year":"2017","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2025.02.012_bib62","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1213\/ANE.0b013e31824f6940","article-title":"Life cycle greenhouse gas emissions of anesthetic drugs","volume":"114","author":"Sherman","year":"2012","journal-title":"Anesth Analg"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T13:18:06Z","timestamp":1762607886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2213219825001837"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.02.012","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Greenhouse Gas Emissions Associated With Severe Asthma Care in the United Kingdom","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}